Risperidone augmentation for treatment-resistant aggression in attention-deficit/hyperactivity disorder: A placebo-controlled pilot study

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 46, Issue 5, 2007, Pages 558-565

  Armenteros, Jorge L ^a   Lewis, John E ^b   Davalos, Marisabel ^b  

^a University of Miami Miller School of Medicine ^*  (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Aggression; Attention deficit hyperactivity disorder; Augmentation; Risperidone

Indexed keywords

AMPHETAMINE; METHYLPHENIDATE; PLACEBO; PSYCHOSTIMULANT AGENT; RISPERIDONE;

ABDOMINAL PAIN; ADD ON THERAPY; AGGRESSION; AGITATION; ARTICLE; ATTENTION DEFICIT DISORDER; BLOOD CELL COUNT; BODY MASS; CHI SQUARE TEST; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG TOLERABILITY; ELECTROLYTE BLOOD LEVEL; FEMALE; HUMAN; INCREASED APPETITE; KIDNEY FUNCTION TEST; MALE; OPTIMAL DRUG DOSE; PATIENT COMPLIANCE; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCHOOL CHILD; SCORING SYSTEM; SIDE EFFECT; SOMNOLENCE; STATISTICAL SIGNIFICANCE; THYROID FUNCTION TEST; TREATMENT RESPONSE; URINALYSIS; VOMITING;

AGGRESSION; ANTIPSYCHOTIC AGENTS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; DOUBLE-BLIND METHOD; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; METHYLPHENIDATE; PILOT PROJECTS; QUESTIONNAIRES; RISPERIDONE; SEVERITY OF ILLNESS INDEX;

EID: 34247370682     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/chi.0b013e3180323354     Document Type: Article

References (30)

1. Abikoff H, Gittelman R (1985), The normalizing effects of methylphenidate on the classroom behavior of ADHD children. J Abnorm Child Psychol 13:33-44
2. Aman MG, De Smedt G, Derivan A, Lyons B, Findling RL, and the Risperidone Disruptive Behavior Study Group (2002), Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence. Am J Psychiatry 159:1337-1346
3. Barkley R (1998), Attention-deficit hyperactivity disorder. Sci Am 279:66-71
4. Brown R, Freeman W, Perrin J et al. (2001), Prevalence and assessment of attention-deficit/hyperactivity disorder in primary care settings. Pediatrics 107:e43
5. Buitelaar JK (2000), Open-label treatment with risperidone of 26 psychiatrically-hospitalized children and adolescents with mixed diagnoses and aggressive behavior. J Child Adolesc Psychopharmacol 10:19-26
6. Buitelaar JK, Van der Gaag RJ, Cohen-Kettenis P, Melman CTM (2001), A randomized controlled trial of risperidone in the treatment of aggression in hospitalized adolescents with subaverage cognitive abilities. J Clin Psychiatry 62:239-248
7. Casat CD, Pearson DA, Van Davelaar MJ, Cherek DR (1995), Methylphenidate effects on a laboratory aggression measure in children with ADHD. Psychopharmacol Bull 31:353-356
8. Conners CK (1997), Conners' Rating Scales: Revised Technical Manual. North Tonawanda, NY: Multi-Health Systems
9. Connor D, Glatt S, Lopez I, Jackson D, Melloni R (2002), Psychopharmacology and aggression. I: A meta-analysis of stimulant effects on overt/covert aggression-related behaviors in ADHD. J Am Acad Child Adolesc Psychiatry 41:253-261
10. Findling RL, McNamara NK, Branicky LA, Schluchter MD, Lemon E, Blumer JL (2000), A double-blind pilot study of risperidone in the treatment of conduct disorder. J Am Acad Child Adolesc Psychiatry 39:509-516
11. Goyette CH, Conners CK, Ulrich RF (1978), Normative data on revised Conners parent and teacher rating scales. J Abnorm Child Psychol 6:221-236
12. Greenhill L, Halperin JM, Abikoff H (1999), Stimulant medications. J Am Acad Child Adolesc Psychiatry 38:503-512
13. Guy W (1976), ECDEU Assessment Manual for Psychopharmacology Revised (Publication ADM 76-338). Washington, DC: U.S. Department of Health, Education, and Welfare
14. Halperin J, McKay K, Grayson R, Newcorn J (2003), Reliability, validity, and preliminary normative data for the Children's Aggression Scale-Teacher Version. J Am Acad Child Adolesc Psychiatry 42:965-971
15. Halperin J, McKay K, Newcorn J (2002), Development, reliability, and validity of the Children's Aggression Scale-Parent Version. J Am Acad Child Adolesc Psychiatry 41:245-252
16. Hinshaw SP, Henker B, Whalen CK (1984), Cognitive-behavioral and pharmacologic interventions for hyperactive boys: comparative and combined effects. J Cons Clin Psychol 52:739-749
17. Klein RG, Abikoff H, Klass E, Ganeles D, Seese LM, Pollack S (1997), Clinical efficacy of methylphenidate in conduct disorder with and without attention deficit hyperactivity disorder. Arch Gen Psychiatry 54:1073-1080
18. Malone RP, Bennett DS, Luebbert JF, et al. (1998), Aggression classification and treatment response. Psychopharmacol Bull 34:41-45
19. Murphy DA, Pelham WE, Lang AR (1992), Aggression in boys with attention deficit-hyperactivity disorder: methylphenidate effects on naturalistically observed aggression, response to provocation, and social information processing. J Abnorm Child Psychol 20:451-466
20. Olfson M, Blanco C, Liu L, Moreno C, Laje G (2006), National trends in outpatient treatment of children and adolescents with antipsychotic drugs. Arch Gen Psychiatry 63:679-685
21. Pelham W, Milich R, Cummings E, Murphy D, Schaughency E, Greiner A (1991), Effects of background anger, provocation, and methylphenidate on emotional arousal and aggressive responding in attention-deficit hyperactivity disordered boys with and without concurrent aggressiveness. J Abnorm Child Psychol 19:407-426
22. Shaffer D, Fisher P, Lucas CP, Dulcan MK, Schwab-Stone ME (2000), Diagnostic Interview Schedule for Children Version IV (NIMH DISCIV): descriptions, differences from previous versions, and reliability of some common diagnoses. J Am Acad Child Adolesc Psychiatry 39:28-38
23. Schur SB, Sikich L, Findling RL, et al. (2003), Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). I: a review. J Am Acad Child Adolesc Psychiatry 42:132-144
24. Snyder R, Turgay A, Aman M, Binder C, Fisman S, Carroll A, and the Risperidone Conduct Study Group (2002), Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs. J Am Acad Child Adolesc Psychiatry 41:1026-1036
25. Stigler KA, Potenza MN, Posey DJ, McDougle CJ (2004), Weight gain associated with atypical antipsychotic use in children and adolescents: prevalence, clinical relevance, and management. Paediatr Drugs 6:33-44
26. Van Bellinghen M, De Troch C (2001), Risperidone in the treatment of behavior disturbances in children and adolescents with borderline intellectual functioning: a double-blind, placebo-controlled pilot trial. J Child Adolesc Psychopharmacol 11:5-13
27. Vitiello B, Behar D, Hunt J, Stoff D, Ricciuti A (1990), Subtyping aggression in children and adolescents. J Neuropsychiatry Clin Neurosci 2:189-192
28. Vitiello B, Stoff DM (1997), Subtypes of aggression and their relevance to child psychiatry. J Am Acad Child Adolesc Psychiatry 36:307-315
29. Werry JS, Aman MG (1975), Methylphenidate and haloperidol in children. Effects on attention, memory, and activity. Arch Gen Psychiatry 32:790-795
30. Whalen CK, Henker B, Swanson JM, Granger D, Kliewer W, Spencer J (1987), Natural social behaviors in hyperactive children: dose effects of methylphenidate. J Cons Clin Psychol 55:187-193